Foundry Partners, LLC Vanda Pharmaceuticals Inc. Transaction History

Foundry Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$6.87 - $10.96 $1.94 Million - $3.09 Million	282,268 New	282,268 $2.09 Million
Q1 2020 May 08, 2020	SELL	$7.5 - $16.8 $341,302 - $764,517	-45,507 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$12.38 - $17.47 $13,816 - $19,496	-1,116 Reduced 2.39%	45,507 $747,000
Q3 2019 Oct 23, 2019	SELL	$12.27 - $15.79 $1,349 - $1,736	-110 Reduced 0.24%	46,623 $619,000
Q2 2019 Jul 18, 2019	SELL	$13.37 - $18.85 $1,925 - $2,714	-144 Reduced 0.31%	46,733 $658,000
Q1 2019 Apr 22, 2019	SELL	$17.59 - $31.05 $58,134 - $102,620	-3,305 Reduced 6.59%	46,877 $863,000
Q4 2018 Jan 10, 2019	SELL	$18.97 - $31.47 $1,612 - $2,674	-85 Reduced 0.17%	50,097 $1.31 Million
Q4 2018 Jan 10, 2019	BUY	$18.97 - $31.47 $1,612 - $2,674	85 Added 0.17%	50,182 $1.15 Million
Q3 2018 Oct 17, 2018	SELL	$18.25 - $23.0 $1,423 - $1,794	-78 Reduced 0.16%	50,182 $1.15 Million
Q2 2018 Jul 19, 2018	SELL	$13.95 - $19.15 $45,616 - $62,620	-3,270 Reduced 6.11%	50,260 $957,000
Q1 2018 May 16, 2018	SELL	$14.05 - $20.2 $332,001 - $477,326	-23,630 Reduced 30.62%	53,530 $902,000
Q4 2017 Jan 25, 2018	SELL	$12.85 - $18.1 $787,525 - $1.11 Million	-61,286 Reduced 44.27%	77,160 $1.17 Million
Q3 2017 Oct 31, 2017	BUY	$15.4 - $18.85 $2.13 Million - $2.61 Million	138,446	138,446 $2.48 Million

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $271M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.